(MENAFN - Comserve) Shibuya-ku, Tokyo, Japan, Japan, Feb 18, 2021, 09:43 /Comserve / -- Competitive Analysis: Acotec Scientific, M.A. Med Alliance, ENDOCOR, AR Baltic Medical, iVascular SLU, Concept Medical, Acrostak, Hexacath, Cardionovum, Biosensors International Group
Drug-Coated Balloons Market by Indication (DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications) Application (Cardiac Catheterization Labs, Hospitals, ASCs) - Global Industry Analysis & Forecast to 2025
Industry Outlook and Trend Analysis
The drug-coated balloons market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Drug-coated balloons (DCBs) are standard (semi-agreeable) angioplasty balloons covered with a cytotoxic chemotherapeutic specialist. Presently, most of commercially accessible drug-coated balloons use paclitaxel. Drug-coated balloons (DCB) are a novel therapeutic procedure for little local coronary conduit infection. However, their wellbeing and efficacy are inadequately characterized in correlation with drug-eluting stents (DES).